Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
62.92
-1.42 (-2.21%)
At close: Jun 26, 2026, 4:00 PM EDT
62.85
-0.07 (-0.11%)
After-hours: Jun 26, 2026, 7:07 PM EDT
Tarsus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Tarsus Pharmaceuticals stock have an average target of 91.29, with a low estimate of 68 and a high estimate of 100. The average target predicts an increase of 45.09% from the current stock price of 62.92.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 27, 2026.
Analyst Ratings
The average analyst rating for Tarsus Pharmaceuticals stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 3, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $100 | Buy | Reiterates | $100 | +58.93% | May 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $88 | Buy | Maintains | $88 | +39.86% | May 26, 2026 |
| Barclays | Barclays | Buy Maintains $100 | Buy | Maintains | $100 | +58.93% | May 15, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $95 | Buy | Reiterates | $95 | +50.99% | May 9, 2026 |
Financial Forecast
Revenue This Year
696.36M
from 451.36M
Increased by 54.28%
Revenue Next Year
904.52M
from 696.36M
Increased by 29.89%
EPS This Year
-0.59
from -1.59
EPS Next Year
2.87
from -0.59
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 704.3M | 988.9M | |
| Avg | 696.4M | 904.5M | |
| Low | 688.0M | 850.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 56.0% | 42.0% | |
| Avg | 54.3% | 29.9% | |
| Low | 52.4% | 22.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.59 | 2.87 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.